Research Reports in Pharmaceuticals

U.S. Anti-aging Supplements Market Size, Share, & Trends Analysis Report By Ingredient (Collagen, Resveratrol, NMN, Vitamins), By Application, By Formulation, By Distribution Channel, And Segment Forecasts, 2025 - 2030

The U.S. anti-aging supplements market was valued at USD 1.39 billion in 2024 and is expected to grow at a CAGR of 7.2% from 2025 to 2030. Growth is driven by increasing health consciousness, rising life expectancy, and a proactive approach to age-related health management among U.S. con... Read More »

June 2025

U.S. Rozanolixizumab (Rystiggo) Market Size, Share & Trends Analysis Report By Indication (Generalized Myasthenia Gravis (gMG), Emerging Pipeline Applications), By Distribution Channel, And Segment Forecasts, 2025 - 2033

The U.S. Rozanolixizumab (Rystiggo) market size was estimated at USD 199.13 million in 2024 and is expected to grow at a CAGR of 7.30% from 2025 to 2033. The U.S. Rozanolixizumab (Rystiggo) market focuses on treating generalized myasthenia gravis (gMG) in adults with anti-AChR or anti-Mu... Read More »

June 2025

Liver Disease Therapeutics Market Size, Share & Trends Analysis Report By Product (Antiviral Drugs, Vaccines, Chemotherapy), By Disease (Hepatitis, Autoimmune Diseases), By Region, And Segment Forecasts, 2025 - 2033

The global liver disease therapeutics market size was estimated at USD 20.31 billion in 2024 and is projected to reach USD 40.29 billion by 2033, growing at a CAGR of 7.9% from 2025 to 2033. Rising cases of NAFLD, hepatitis, and alcohol-related liver conditions, advancements in drug... Read More »

June 2025

Germany Pharmaceutical Market Size, Share & Trends Analysis Report By Molecule Type, By Product, By Type, By Disease, By Age Group, By Route Of Administration, By Distribution Channel, By Country, And Segment Forecasts, 2025 - 2033

The Germany pharmaceutical market size was estimated at USD 95.11 billion in 2024 and is expected to grow at a CAGR of 5.31% from 2025 to 2033. The growth is driven by advances in digital health technologies supporting drug development and personalized medicine, such as AI and genome seq... Read More »

June 2025

Vaccine Market Size, Share & Trends Analysis Report By Type (Subunit, mRNA), By Route Of Administration (Oral), By Disease Indication (HPV, MMR), By Age Group (Adult), By Distribution Channel, By Region, And Segment Forecasts, 2025 - 2033

The global vaccine market size was estimated at USD 67.37 billion in 2024 and is projected to reach USD 115.77 billion by 2033, growing at a CAGR of 5.98% from 2025 to 2033. The market has been expanding globally, with an increase in vaccines targeting diseases that predominantly affect ... Read More »

June 2025

Onychomycosis Market Size, Share & Trends Analysis Report By Type (Distal Subungual Onychomycosis, White Superficial Onychomycosis, Proximal Subungual Onychomycosis), By Treatment (Oral, Topical), By Region, And Segment Forecasts, 2025 - 2033

The global onychomycosis market was estimated at USD 3.81 billion in 2024 and is projected to reach USD 5.74 billion by 2033, growing at a CAGR of 4.7% from 2025 to 2033. The market is driven by the rising prevalence of fungal nail infections, increasing incidence of chronic conditions s... Read More »

June 2025

Peanut Allergy Treatment Market Size, Share & Trends Analysis Report By Drug Class (Antihistamines, Epinephrine, Immunotherapies), By Route Of Administration, By Distribution Channel, By Region, And Segment Forecasts, 2025 - 2033

The global peanut allergy treatment market size was estimated at USD 536.8 million in 2024 and is projected to reach USD 1,461.5 million by 2033, growing at a CAGR of 11.43% from 2025 to 2033. This market is witnessing robust expansion, fueled by rising peanut allergy prevalence and inno... Read More »

June 2025

U.S. Ultomiris Drug Market Size, Share & Trends Analysis Report By Indication (Paroxysmal Nocturnal Hemoglobinuria (PNH), Atypical Hemolytic Uremic Syndrome (aHUS)), By End Use (Adult, Pediatric), By Distribution Channel, And Segment Forecasts, 2025 - 2033

The U.S. ultomiris drug market size was estimated at USD 1.46 billion in 2024 and is projected to reach USD 8.14 billion by 2033, growing at a CAGR of 19.93% from 2025 to 2033. Ultomiris continues to gain traction due to its extended dosing interval, which improves patient compliance and... Read More »

June 2025

UK Alzheimer’s Therapeutics Market Size, Share & Trends Analysis Report By Product (Cholinesterase Inhibitors, NMDA Receptor Antagonist Combination Drug), By End Use (Hospital Pharmacy, Retail Pharmacy), And Segment Forecasts, 2025 - 2033

The UK Alzheimer’s therapeutics market size was estimated at USD 263.66 million in 2024 and is projected to reach USD 498.80 million by 2033, growing at a CAGR of 7.84% from 2025 to 2033. The increasing prevalence of Alzheimer’s disease in the UK is driving demand for effecti... Read More »

June 2025

U.S. Zilbrysq (Zilucoplan) Market Size, Share & Trends Analysis Report By Indication (Generalized Myasthenia Gravis (gMG)), By Distribution Channel (Specialty Pharmacies, Hospital/Institution-Based, Home Healthcare Providers), And Segment Forecasts, 2025 - 2030

The U.S. Zilbrysq (Zilucoplan) market size was estimated at USD 60.61 million in 2024 and is projected to grow at a CAGR of 21.64% from 2025 to 2030. The U.S. Zilbrysq (Zilucoplan) industry is witnessing robust growth following its FDA approval in October 2023 for the treatment of anti-A... Read More »

June 2025

Zilbrysq (Zilucoplan) Market Size, Share & Trends Analysis Report By Indication (Generalized Myasthenia Gravis), By Distribution Channel (Specialty Pharmacies, Hospital/Institution-Based Pharmacies, Home Healthcare Providers), By Region, And Segment Forecasts, 2025 - 2030

The global zilbrysq (zilucoplan) market size was estimated at USD 77.92 million in 2024 and is projected to reach USD 679.58 million by 2030, growing at a CAGR of 28.39% from 2025 to 2030. The market is experiencing significant growth, driven by its regulatory approvals in key markets su... Read More »

June 2025

U.S. Enteral Feeding Formulas Market Size, Share & Trends Analysis Report By Product, By Flow Type, By Stage (Adults, Pediatrics), By Indication (Cancer Care, Diabetes), By End use (Hospitals, Home Care), By Sales Channel, And Segment Forecasts, 2025 - 2030

The U.S. enteral feeding formulas market size was estimated at USD 2.06 billion in 2024 and is projected to grow at a CAGR of 5.7% from 2025 to 2030. The increasing prevalence of chronic diseases, including cancer, stroke, multiple sclerosis, dementia, chronic liver disease, chronic obst... Read More »

June 2025

Vyvgart (Efgartigimod) Market Size, Share & Trends Analysis Report By Indication (Generalized Myasthenia Gravis (gMG), Chronic Inflammatory Demyelinating Polyneuropathy (CIDP)), By Route of Administration, By Region, And Segment Forecasts, 2025 - 2030

The global Vyvgart (Efgartigimod) market size was estimated at USD 2.19 billion in 2024 and is projected to reach USD 5.50 billion by 2030, growing at a CAGR of 13.6% from 2025 to 2030. The market is experiencing significant growth, driven by several key factors. The increasing prevalenc... Read More »

June 2025

Alopecia Market Size, Share & Trends Analysis Report By Disease Type (Alopecia Areata, Cicatricial, Traction, Androgenetic Alopecia), By Treatment, By Gender, By Sales Channel, By End Use, By Region, And Segment Forecasts, 2025 - 2030

The global alopecia market size was estimated at USD 9.48 billion in 2024 and is projected to reach USD 16.02 billion by 2030, growing at a CAGR of 8.7% from 2025 to 2030. One of the major driving factors for the market is the increasing awareness regarding alopecia treatment options, as... Read More »

June 2025

Hemophilia Market Size, Share & Trends Analysis Report By Type (Hemophilia A, Hemophilia B), By Treatment Type (On-demand, Cure), By Therapy, By Distribution Channel, By Region, And Segment Forecasts, 2025 - 2030

The global hemophilia market size was estimated at USD 14.11 billion in 2024 and is projected to reach USD 21.07 billion by 2030, growing at a CAGR of 6.91% from 2025 to 2030. The major factor driving the market is gene therapy approval, and multiple other candidates in various pipeline ... Read More »

June 2025

Multiple Sclerosis Therapeutic Market Size, Share & Trends Analysis Report By Drug Class (Immunosuppressants, Immunostimulants), By Route Of Administration (Oral, Injectable), By Distribution Channel, By Region, And Segment Forecasts, 2025 - 2030

The global multiple sclerosis therapeutic market size was estimated at USD 27.39 billion in 2024 and is projected to reach USD 38.62 billion by 2030, growing at a CAGR of 5.93% from 2025 to 2030. The market growth is due to the rise in the global prevalence of the disease, and the advanc... Read More »

June 2025

Europe Pharmaceutical Market Size, Share & Trends Analysis Report By Molecule, By Product (Branded, Generics), By Type (Prescription, OTC), By Disease, By Age Group, By Route Of Administration, By Distribution Channel, By Region, And Segment Forecasts, 2025 - 2030

The Europe pharmaceutical market size was estimated at USD 488.05 billion in 2024 and is projected to grow at a CAGR of 5.90% from 2025 to 2030. Several factors, including an aging population, advancements in medical technology, and rising healthcare spending, drive market growth. In add... Read More »

June 2025

U.S. Inflammatory Bowel Disease Treatment Market Size, Share & Trends Analysis Report By Type (Crohn's Disease, Ulcerative Colitis), By Drug Class, By Route Of Administration, By Distribution Channel, By Region, And Segment Forecasts, 2025 - 2030

The U.S. inflammatory bowel disease treatment market size was estimated at USD 13.12 billion in 2024 and is projected to grow at a CAGR of 2.7% from 2025 to 2030. The market is driven by the rising adoption of advanced therapeutic options such as biologics, JAK inhibitors, and personaliz... Read More »

June 2025

India GLP-1 Receptor Agonist Market Size, Share & Trends Analysis Report By Application (Diabetes, Obesity), By Route of Administration (Parenteral, Oral), By Product, By Distribution Channel, And Segment Forecasts, 2025 - 2030

The India GLP-1 receptor agonist market size was estimated at USD 110.55 million in 2024 and is projected to grow at a CAGR of 34.3% from 2025 to 2030. The market is driven by the rising incidence of chronic conditions such as type 2 diabetes and obesity, increasing R&D activities fo... Read More »

June 2025

Ultomiris Drug Market Size, Share & Trends Analysis Report By Indication (PNH, Myasthenia Gravis, Neuromyelitis Optica Spectrum Disorder), By End Use, By Distribution Channel, By Region, And Segment Forecasts, 2025 - 2030

The global ultomiris drug market size was estimated at USD 3.92 billion in 2024 and is projected to reach USD 18.03 billion by 2030, growing at a CAGR of 28.47% from 2025 to 2030. The global Ultomiris (ravulizumab) drug industry is experiencing strong momentum due to the rising demand fo... Read More »

May 2025